Opendata, web and dolomites

REGIONS4PERMED SIGNED

INTERREGIONAL COORDINATION FOR A FAST AND DEEP UPTAKE OF PERSONALISED HEALTH

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REGIONS4PERMED project word cloud

Explore the words cloud of the REGIONS4PERMED project. It provides you a very rough idea of what is the project "REGIONS4PERMED" about.

episodic    technologies    emergent    regional    direct    interregional    trust    cutting    fact    national    intervene    size    industrial    joint    channel    away    ph    tests    reactive    health    cooperation    deployment    regions4permed    diagnostic    illness    risk    stratifying    investment    severe    investments    fits    medicine    shift    leap    predict    stakeholder    esif    nowadays    edge    pm    stakeholders    industry    upstream    integrate    uses    strengthen    council    molecular    2020    flourish    preventive    link    accelerate    paradigm    symptoms    lacks    fragmented    onset    model    stable    therapies    care    policies    action    coordinate    placement    create    stratify    drawback    vanguard    reinforce    manner    treatment    healthcare    patients    aligning    efforts    genomic    personalised    specialisation    innovation    individuals    technological    citizens    predictive    alone    participatory    huge    leverage    functional    acute   

Project "REGIONS4PERMED" data sheet

The following table provides information about the project.

Coordinator
FONDAZIONE TOSCANA LIFE SCIENCES 

Organization address
address: VIA FIORENTINA 1
city: SIENA
postcode: 53100
website: www.toscanalifesciences.org

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 1˙720˙000 €
 EC max contribution 1˙677˙500 € (98%)
 Programme 1. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme CSA
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2022-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FONDAZIONE TOSCANA LIFE SCIENCES IT (SIENA) coordinator 587˙750.00
2    SACHSISCHES STAATSMINISTERIUM FUR WISSENSCHAFT UND KUNST DE (Dresden) participant 336˙500.00
3    FONDAZIONE REGIONALE PER LA RICERCA BIOMEDICA IT (MILANO) participant 270˙250.00
4    AXENCIA GALEGA PARA A XESTION DO CONECEMENTO EN SAUDE ES (SANTIAGO DE COMPOSTELA) participant 251˙500.00
5    Urzad Marszalkowski Wojewodztwa Dolnoslaskiego PL (Wroclaw) participant 189˙000.00
6    UNIWERSYTET MEDYCZNY IM PIASTOW SLASKICH WE WROCLAWIU PL (WROCLAW) participant 42˙500.00

Map

 Project objective

Personalised medicine (PM) represents a paradigm shift away from a ‘one size fits all’ approach to the treatment and care of patients with a particular condition, to one which uses emergent approaches in particular technological areas such as diagnostic tests, functional genomic technologies, molecular pathways (etc.) to better manage patients’ health and to target therapies. Nowadays the challenge for national and regional authorities is to enable the shift from a REACTIVE healthcare system (based on episodic and acute care model) to a PREVENTIVE (stratifying at-risk individuals and ensure that preventive action is taken to intervene well before the onset of symptoms, let alone illness) and PREDICTIVE (leverage and integrate cutting-edge technologies to not only stratify risk, but even predict risk and intervene even further upstream) system – the so called Personalised Health (PH). In the face of this potential huge leap forward, the fact that personalised health lacks the cooperation and coordination needed to organise the still very fragmented field is a severe drawback to its development and to the placement of investments in an effective manner. For this reason, it is crucial to direct major efforts towards coordinating and aligning relevant stakeholders in personalised health action across Europe and beyond; create a participatory approach; build trust; enable a multi-stakeholder process; channel investments towards Personalised Health. All this considered, Regions4PerMed will coordinate regional policies and innovation programmes in Personalised Medicine and Personalised Health to accelerate the deployment of PH for citizens and patients. The project will reinforce the cooperation between H 2020 and ESIF on PH aspects; Strengthen industrial specialisation areas in Europe and allow PH to flourish as an Emerging Industry; Enable interregional joint investment on PH, including a stable link with Vanguard Initiative and with the European Innovation Council.

 Deliverables

List of deliverables.
Advisory Board Other 2019-07-23 15:15:20
Kick-off conference Report Documents, reports 2019-07-23 15:15:21
ORDP Open Research Data Pilot 2019-07-23 15:15:14

Take a look to the deliverables list in detail:  detailed list of REGIONS4PERMED deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REGIONS4PERMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REGIONS4PERMED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.6.)

EBRA (2018)

European Brain Research Area

Read More  

SINO-EU-PerMed (2020)

Widening Sino‐EU policy and research cooperation in Personalised Medicine

Read More  

PERMIT (2020)

PERsonalised MedicIne Trials

Read More